Only ⅔ of FDA-approved biosimilars have launched.Measles outbreak continues.UnitedHealth profits fall.Super-Earths.‘Bone Collector’ caterpillars.NFL Draft comes to Green Bay.
October 20, 2026
- GSK Immunotherapy Gets Accelerated FDA Approval for Treating Rectal Cancer
- At the Houston Summit, Healthcare Leaders Put People at the Center of Innovation
- A Radical Proposal to Preserve Cell and Gene Therapy Innovation
- KFF Tracking Poll on Health Information and Trust: Fall 2026 Update on Vaccine Views
Headlines
